387350-92-7 Usage
General Description
1-(Cloromethyl)-4,5-dihydro-1H-imidazole hydrochloride is a chemical compound used in the pharmaceutical industry. It is an intermediate in the synthesis of various drugs and can also be used as a reagent in organic chemistry. The hydrochloride salt form of the compound makes it more stable and suitable for use in aqueous solvents. It is a white crystalline solid that is soluble in water and polar organic solvents. The compound is used in the production of pharmaceuticals and research chemicals, and it is important to handle it with care and follow proper safety protocols when working with it.
Check Digit Verification of cas no
The CAS Registry Mumber 387350-92-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,7,3,5 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 387350-92:
(8*3)+(7*8)+(6*7)+(5*3)+(4*5)+(3*0)+(2*9)+(1*2)=177
177 % 10 = 7
So 387350-92-7 is a valid CAS Registry Number.
387350-92-7Relevant articles and documents
A urea-biphenyl compound and its composition and use thereof
-
Paragraph 0155; 0156, (2017/08/25)
The invention relates to biphenyl derivatives as well as a preparation method and a pharmaceutical composition and application thereof on medicines. And particularly, the invention relates to novel urea-substituted biphenyl derivatives as well as a pharma
BICYCLIC GPR119 MODULATORS
-
Page/Page column 38, (2012/06/15)
The present invention relates to compounds of Formula (I) that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of GPR119 receptor activity. The invention also relates to the process for preparation of the compounds, pharmaceutical compositions thereof. The invention further relates to methods o f treating, preventing and/or managing diseases, disorders syndromes or conditions associated with the modulation of GPR119 receptor by using either alone or in combinations of Formula (I)